Micro and Nano Systems for Biophysical Studies of Cells and Small Organisms provides a comprehensive introduction to the state-of-the-art micro and nano systems that have recently been developed and applied to biophysical studies of cells and small organisms. These micro and nano systems span from microelectromechanical systems (MEMS) and microfluidic devices to robotic micro-nanomanipulation systems. These biophysical studies range from cell mechanics to the neural science of worms and Drosophila. This book will help readers understand the fundamentals surrounding the development of these tools and teach them the most recent advances in cellular and organismal biophysics enabled by these technologies.

Consumer electronics and computers redefined life and work in the twentieth century. In Inventing the Electronic Century, Pulitzer Prize-winning business historian Alfred D. Chandler, Jr. traces their origins and worldwide development. From electronics prime mover RCA in the 1920s to Sony and Matsushita's dramatic rise in the 1970s; from IBM's dominance in computer technology in the 1950s to Microsoft's stunning example of the creation of competitive advantage, this masterful analysis is essential reading for every manager and student of technology. "Thought provoking. Chandler develops the history of the consumer electronics and computer industries with the questioning attitude of a teacher: always searching for the lessons behind the story." --Andrew S. Grove, Chairman of the Board, Intel "Offers a rich cast of characters and companies, compelling stories, and deep understanding of economic forces." --Hal Varian, School of Information Management and Systems, University of California, Berkeley

This book integrates the experimental procedures and theoretical principles for undergraduate, postgraduate, academicians and researchers in the area of agriculture and life sciences. The experiments have been updated and extended to reflect developments in the respective fields. In-text worked examples are again used to enhance student’s understanding of each topic. The book is designed to provide students with the experience of how scientists use their knowledge to understand real-world science related issues that confront them in their professional lives. Experimental procedures and troubleshooting of data are emphasised throughout the book. The book integrates theory and practices to ensure students understand why and how each technique is used.

The Electronic Health Record: Ethical Considerations analyses the ethical issues that surround the construction, maintenance, storage, use, linkage, manipulation and communication of electronic health records. Its purpose is to provide ethical guidance to formulate and implement policies at the local, national and global level, and to provide the basis for global certification in health information ethics. Electronic health records (EHRs) are increasingly replacing the use of paper-based records in the delivery of health care. They are integral to providing eHealth, telehealth, mHealth and pHealth - all of which are increasingly replacing direct and personal physician-patient interaction - as well as in the developing field of artificial intelligence and expert systems in health care. The book supplements considerations that are raised by national and international regulations dealing with electronic records in general, for instance the General Data Protection Regulation of the European Union. This book is a valuable resource for physicians, health care administrators and workers, IT service providers and several members of biomedical field who are interested in learning more about how to ethically manage health data.

Single-Cell Omics: Volume 1: Technological Advances and Applications provides the latest technological developments and applications of single-cell technologies in the field of biomedicine. In the current era of precision medicine, the single-cell omics technology is highly promising due to its potential in diagnosis, prognosis and therapeutics. Sections in the book cover single-cell omics research and applications, diverse technologies applied in the topic, such as pangenomics, metabolomics, and multi-omics of single cells, data analysis, and several applications of single-cell omics within the biomedical field, for example in cancer, metabolic and neuro diseases, immunology, pharmacogenomics, personalized medicine and reproductive health. This book is a valuable source for bioinformaticians, molecular diagnostic researchers, clinicians and members of the biomedical field who are interested in understanding more about single-cell omics and its potential for research and diagnosis.

Biotechnology and law are inextricable. Patent, regulatory, and contract law profoundly shape the biotech industry, and each of these practice areas is deeply intertwined with the science it governs. Yet many in this industry lack even a basic grasp of these laws, jeopardizing their business success as a result. This book is an essential introduction to biotechnology law for scientists, startup founders, regulatory specialists, patent liaisons, investors, academics, students, and other nonattorneys with biotech backgrounds. It covers core topics such as patentability, patent prosecution and infringement, patent opinions, the development and FDA approval of small-molecule and biologic drugs, regulatory exclusivity, generic drugs and ANDA litigation, biosimilars and the patent dance, patent licenses, and collaboration agreements. Written with scientists in mind, Biotechnology Law is a clear, concise, and entirely practical primer on the topic, replete with straightforward, real-world examples to illustrate each key concept. Understanding the legal machinery through which science becomes business is not a luxury-it is a crucial part of a scientist's training. Alan J. Morrison's expert treatment embraces this new reality.

The biohealthcare executive in upper-middle management confronts leadership challenges unique to their industry: they manage highly specialized knowledge workers and innovators, compete at the speed of technology, work in a highly regulated environment where "free speech" often does not apply due to patient safety and privacy concerns, and increasingly are leading virtual teams who may be located in different parts of the world. Practical leadership for biopharmaceutical executives is a guide that strips away the theory and meets head-on the practical leadership challenges these executives face on a daily basis, and provides these "innovator leaders" with the tools to lead effectively in the face of technological complexity.

With the advent of electronic medical records years ago and the increasing capabilities of computers, our healthcare systems are sitting on growing mountains of data. Not only does the data grow from patient volume but the type of data we store is also growing exponentially. Practical Predictive Analytics and Decisioning Systems for Medicine provides research tools to analyze these large amounts of data and addresses some of the most pressing issues and challenges where data integrity is compromised: patient safety, patient communication, and patient information. Through the use of predictive analytic models and applications, this book is an invaluable resource to predict more accurate outcomes to help improve quality care in the healthcare and medical industries in the most cost-efficient manner. Practical Predictive Analytics and Decisioning Systems for Medicine provides the basics of predictive analytics for those new to the area and focuses on general philosophy and activities in the healthcare and medical system. It explains why predictive models are important, and how they can be applied to the predictive analysis process in order to solve real industry problems. Researchers need this valuable resource to improve data analysis skills and make more accurate and cost-effective decisions.

After World War II, several late-developing countries registered astonishingly high growth rates under strong state direction, making use of smart investment strategies, turnkey factories, and reverse-engineering, and taking advantage of the postwar global economic boom. Among these economic miracles were postwar Japan and, in the 1960s and 1970s, the so-called Asian Tigers Singapore, South Korea, and Taiwan whose experiences epitomized the analytic category of the "developmental state."

In Betting on Biotech, Joseph Wong examines the emerging biotechnology sector in each of these three industrial dynamos. They have invested billions of dollars in biotech industries since the 1990s, but commercial blockbusters and commensurate profits have not followed. Industrial upgrading at the cutting edge of technological innovation is vastly different from the dynamics of earlier practices in established industries.

The profound uncertainties of life-science-based industries such as biotech have forced these nations to confront a new logic of industry development, one in which past strategies of picking and making winners have given way to a new strategy of throwing resources at what remain very long shots. Betting on Biotech illuminates a new political economy of industrial technology innovation in places where one would reasonably expect tremendous potential yet where billion-dollar bets in biotech continue to teeter on the brink of spectacular failure."

The Committee on Finance of the United States Senate requested the Commission to examine the competitive conditions affecting certain industries that are developing and adopting new industrial biotechnology (IB) processes and products. IB was defined as the manufacture of liquid fuel and chemical products using enzymes, micro-organisms, or renewable resources. The application of IB can improve the efficiency of the industries and lead to the development of new products. Thus, this book focuses on U.S. liquid biofuel producers and firms in the U.S. chemical industry. An analysis of the current impact of IB on the U.S. economy is also provided. Industrial biotechnology (IB) activities in the U.S. by the chemical and liquid fuel industries increased substantially during the 2004-2007 period. Sales of U.S. produced bio-based products, for example, increased by over 30% during the period. As discussed in this book, much of this growth is accounted for by the ethanol and biodiesel industries, which are strongly supported by government tax incentives or mandatory use regulations, or both.

Best Practices in Biotechnology Education describes a wide variety of programs from high school through Ph.D. programs. Some are in their first years, whereas others are quite mature and have diversified to offer myriad degree and certificate options. There is also strong international representation, with programs from Australia, Canada, New Zealand, South Africa, and the United States. Best Practices in Biotechnology Education is directed at faculty seeking to start or expand biotechnology education programs; policy-makers and economic developers seeking to help meet workforce needs; and, students, scientists, and business professionals looking to enter the industry or upgrade their existing skills.

How do corporations achieve change? In the first analytic book about Hewlett-Packard, Deone Zell also offers an ethnography of corporate redesign, documenting Hewlett-Packard's radical reorganization of both a manufacturing and a research division. Because she writes from within the process as it unfolds, Zell is able to demonstrate how the inclusion of employees in every step of redesign can inspire the knowledge and commitment to transform an organization.

Hewlett-Packard is among a growing number of companies in the United States exploring what is called sociotechnical systems (STS) redesign. As competitive pressures have grown, interest in STS has increased because it has the potential to catalyze comprehensive organizational change and avoid the pitfalls of a piecemeal or small-scale approach. STS works from the ground up, involving front-line employees in analysis and redesign of the entire organization and in explicit examination of an organization's culture.

In Hewlett-Packard's California Personal Computer Division, production operators worked alongside managers to redesign their printed circuit assembly line into self-managing teams of employees. In the Santa Clara Division, a very different workforce of engineers, initially unwilling to standardize their creativity, had to develop commercial applications and become more responsive to customers in order to survive.

On the basis of Hewlett-Packard's success, Zell concludes that, with top-level support and a high investment of resources at the outset, redesign can inspire relatively rapid change, especially suitable for organizations in fast-paced environments. As one H-P manager commented, "Empowerment is no longer a nice thing to do. It is now a business imperative."

Software comes from India, hardware comes from China. Why is that? Why did China and India take such different paths to global dominance in new high-tech industries? Will their paths continue to diverge or converge? How can other countries learn from their successes - and failures - in reaching global scale in new industries? To answer these questions, this book presents the first rigorous comparison of the growth of the IT industries in China and India, based on interviews with over 300 companies. It explains the different growth paths of the software and hardware sectors in each country, providing insights into the factors behind the emergence of China and India as global economic powers. It provides a compelling case study of how differences in economic policies and the investment climate affect industrial growth. This book sheds new light on common debates on "China versus India," on why India is the software capital of the world while China is a manufacturing powerhouse. It refutes common myths about the growth of these industries - for example, the role of Non-Resident Indians or the Y2K problem in the growth of the Indian software industry, the role of government intervention in industrial growth, and the relative size of China and India's software industries.

Thanks to the digital technology revolution, cameras are everywhere PDAs, phones, anywhere you can put an imaging chip and a lens. Battling to usurp this two-billion-dollar market is a Silicon Valley company, Foveon, whose technology not only produces a superior image but also may become the eye in artificially intelligent machines. Behind Foveon are two legendary figures who made the personal computer possible: Carver Mead of Caltech, one of the founding fathers of information technology, and Federico Faggin, inventor of the CPU the chip that runs every computer. George Gilder has covered the wizards of high tech for twenty-five years and has an insider's knowledge of Silicon Valley and the unpredictable mix of genius, drive, and luck that can turn a startup into a Fortune 500 company. "The Silicon Eye" is a rollicking narrative of some of the smartest and most colorful people on earth and their race to transform an entire industry."

Find out from an industry veteran exactly what you need to do to become a game designer, tester, artist, producer, programmer, writer, soundtrack composer, videographer, or sales/marketing professional. You’ll get full-spectrum coverage of positions available within the game industry as well as details on how a game is created--from start to finish--and much more.

HOW TO BRIDGE THE GAP BETWEEN TECHNOLOGY AND SERVICES

FEATURING ITS OWN REGULARLY UPDATED WEBSITE, TELECOM CONVERGENCE IS THE ONLY SURVIVAL MANUAL YOU NEED FOR THE BRAVE NEW WORLD OF TELECOM

In this new edition of Telecommunications Convergence, globally recognized telecom guru Steven Shepard gives you a life raft for the whirlpool of todays tech market. With the keen analytical skills and deep knowledge of the industry that have earned him marquee status at telecom conferences around the world, Shepard breaks down the key questions you must answer for your own company and career.

Steven Shepard predicted the current overcapacity, convergence shakeout, and downturn in telecom. Now, in this second edition, he gives you nearly 300 new pages of solutions that work--an almost entirely new book. With this information you and your company can survive--and even thrive--in the challenging environment he forecast.

If youre serious about telecom, you need Shepards technology, service, and management answers to the most critical questions you face:

* What survival strategies will work for my company?

* How do I build a company-sparing blueprint?

* Can management and network hierarchy changes improve the outcome?

* Capability: build or buy?

* What are the smart companies doing right now?

* And most important of all--whats next?

Engineers and other technical professionals are increasingly presented with the opportunity of running their own businesses as entrepreneurs. In other circumstances, particularly in times of great change in industry, they may be considered 'corporate entrepreneurs', leading divisions of larger organisations in an entrepreneurial fashion. This book aims to support the engineer finding him/herself in this position. It looks at the many issues confronting the technical professional faced with the task of leading a company, or a semi-autonomous unit within a company, with clarity and direction in a changing environment. It focuses particularly on: designing the business to meet the requirements of the marketplace financial design of the business and raising venture capital alliances and acquisitions, management buyouts and buyins The material will be useful to three groups of engineers: those who are setting up their own businesses or running companies in changing markets, those who are presented with a management-buyout opportunity, and those who wish simply to broaden their awareness of commercial issues.

"We should be grateful to Ostry and Nelson for giving clarity and balance to interrelated subjects too often dominated by passion and muddle." Keith Pavitt, University of Sussex Sylvia Ostry is chair of the Centre for International Studies, University of Toronto. Richard R. Nelson is professor of international and public affairs, business, and law at Columbia University.

This work is part of the Integrating National Economies series. As global markets for goods, services and financial assets have become increasingly integrated, national governments no longer have as much control over economic markets. With the completion of the Uruguay Round of the GATT talks, the world economy has entered a fresh phase requiring different rules and different levels of international cooperation. Policies once thought to be entirely domestic and appropriately determined by national political institutions, are now subject to international constraints. Cogent analysis of this deeper integration of the world economy, and guidelines for government policies, are urgent priorities. This series aims to meet these needs over a range of 21 books by some of the world's leading economists, political scientists, foreign policy specialists and government officials.

The USA has often failed to capitalise on its technological breakthroughs. This analysis of the weaknesses and strengths of US high technology warns that until the US learns to reconnect research and development with production, foreign companies will continue to prevail in the world marketplace.

This book focuses on the challenges of competition in television broadcasting markets. How is the evolution from a two-sided market to platform economics reshaping competition in television broadcasting? How are new market dynamics changing competition for content creation and acquisition and the revenue streams? Will content remain king? Or will new competitive dynamics undermine the sustainable creation of high quality content, especially in small media markets?

The secret history of the invention that changed everything and became the most profitable product in the world. Odds are that as you read this, an iPhone is within reach. But before Steve Jobs introduced us to 'the one device', as he called it, a mobile phone was merely what you used to make calls on the go. How did the iPhone transform our world and turn Apple into the most valuable company ever? Veteran technology journalist Brian Merchant reveals the inside story you won't hear from Cupertino - based on his exclusive interviews with the engineers, inventors and developers who guided every stage of the iPhone's creation. This deep dive takes you from inside 1 Infinite Loop to nineteenth-century France to WWII America, from the driest place on earth to a Kenyan pit of toxic e-waste, and even deep inside Shenzhen's notorious 'suicide factories'. It's a first-hand look at how the cutting-edge tech that makes the world work - touch screens, motion trackers and even AI - made its way into our pockets. The One Device is a road map for design and engineering genius, an anthropology of the modern age and an unprecedented view into one of the most secretive companies in history. This is the untold account, ten years in the making, of the device that changed everything.

This volume demonstrates show cost analysis can be adapted to MEMS, taking into account the wide range of processes and equipment, the major differences with the established semiconductor industry, and the presence of both large-scale, product-orientated manufacturers and small- and medium-scale foundries. The content examines the processes and equipment sufficiently for the reader to appreciate how costs arise. It examines representative costs are examined in sufficient detail and accuracy for specific equipment, processes, products, or foundries to show how financial models can be introduced to estimate the cost and price for a MEMS product.